Concourse Financial Group Securities’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6592 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7203 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7198 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7209 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7207 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7138 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6972 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6808 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6566 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6578 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6405 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6347 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6229 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6182 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5995 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5795 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5602 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5447 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5234 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5095 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5058 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4992 |
|